亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) in advanced-stage lung cancer

医学 阶段(地层学) 癌症 淋巴细胞 炎症 肺癌 中性粒细胞与淋巴细胞比率 血小板 免疫学 内科学 病理 生物 古生物学
作者
Ayşen Evkan Öztürk,Berna Kömürcüoğlu,Gamze Karakurt,Özgür Öztürk
出处
期刊:Journal of Cancer Research and Therapeutics [BioMed Central]
卷期号:20 (3): 893-897 被引量:1
标识
DOI:10.4103/jcrt.jcrt_1762_20
摘要

Lung cancer is the most common type of cancer that causes death worldwide. Systemic inflammation has been shown to play a role in cancer etiopathogenesis and can be activated from oncogenic changes in cancer cells. In our study, the prognostic effects of inflammatory parameters calculated from serum were investigated in lung cancer.One hundred fifteen patients with locally advanced and advanced lung cancer who were diagnosed in our chest diseases clinic between 2013 and 2015 were retrospectively analyzed. The relationship between advanced lung cancer inflammation index (ALI index), serum neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) levels at the time of diagnosis were calculated, and their relationship with overall survival (OS), disease-free survival, and the treatment response and their effect on predicting prognosis were investigated.When the ALI value was examined in the group with non-small cell lung, the OS was found to be 9.018 months in the group over 18 years of age and it was 3.78 months in the group below. Low ALI index was significantly associated with short survival (P <.05). When the NLR values were examined in the entire patient group, OS more than 5 was 5.95 months and less than 9.63 months. A high NLR value was significantly associated with short survival (P <.05). No significant relationships were detected between PLR and OS. When the determined cut-off values were used, no significant correlation was found between NLR, ALI, and PLR levels and progression-free survival (P >.05).In our study, it was concluded that elevated NLR levels and low ALI values at the time of diagnosis of advanced-stage lung cancer were associated with poor survival, and those values may be useful in predicting survival and prognosis when the cut-off values were used. These parameters can be useful in routine use because they can be easily calculated without additional costs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
在水一方应助孙伟健采纳,获得10
6秒前
今后应助孙伟健采纳,获得10
18秒前
24秒前
25秒前
25秒前
孙伟健发布了新的文献求助10
29秒前
孙伟健发布了新的文献求助10
29秒前
孙伟健发布了新的文献求助10
29秒前
50秒前
啾啾发布了新的文献求助10
55秒前
1分钟前
大模型应助啾啾采纳,获得10
1分钟前
柳贯一发布了新的文献求助10
1分钟前
斑鸠津完成签到,获得积分10
1分钟前
1分钟前
Yumm完成签到 ,获得积分10
1分钟前
又又发布了新的文献求助10
1分钟前
爆米花应助孙伟健采纳,获得10
1分钟前
搜集达人应助又又采纳,获得10
1分钟前
星辰大海应助孙伟健采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
ngan0901发布了新的文献求助10
2分钟前
又又发布了新的文献求助10
2分钟前
孙伟健发布了新的文献求助10
2分钟前
孙伟健发布了新的文献求助10
2分钟前
3分钟前
赘婿应助科研通管家采纳,获得30
3分钟前
可爱的函函应助AliceDu采纳,获得10
3分钟前
3分钟前
AliceDu发布了新的文献求助10
3分钟前
daixan89完成签到 ,获得积分10
3分钟前
4分钟前
StevenWu1发布了新的文献求助10
4分钟前
FashionBoy应助孙伟健采纳,获得10
4分钟前
李健的小迷弟应助孙伟健采纳,获得10
5分钟前
充电宝应助端庄的灵寒采纳,获得30
5分钟前
传奇3应助孙伟健采纳,获得10
5分钟前
高分求助中
Cronologia da história de Macau 1600
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Intentional optical interference with precision weapons (in Russian) Преднамеренные оптические помехи высокоточному оружию 1000
Atlas of Anatomy 5th original digital 2025的PDF高清电子版(非压缩版,大小约400-600兆,能更大就更好了) 1000
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6187689
求助须知:如何正确求助?哪些是违规求助? 8015106
关于积分的说明 16672687
捐赠科研通 5285616
什么是DOI,文献DOI怎么找? 2817504
邀请新用户注册赠送积分活动 1797074
关于科研通互助平台的介绍 1661273